Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Childress

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of Attention Disorders|April 11, 2024
A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical TrialsValerie K Arnold, Frank A López, Ann C Childress, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2008
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorderTimothy E Wilens, Samuel W Boellner, Frank A López, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 28, 2018
Fundamentals of leading, tools for managing, and strategies for sustaining changeTravis B Dick, Nathan R Ash, B C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|August 30, 2019
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across SettingsAnn C Childress, Andrew J Cutler, Andrea Marraffino, et al.
Journal of Global Antimicrobial Resistance|September 14, 2017
Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA)Jayasimha Rao, Dwi Susanti, Johnathon C Childress, et al.
Abdominal Imaging|September 7, 2014
Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancerD I Glazer, M S Davenport, S Khalatbari, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of Attention Disorders|April 11, 2024
A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical TrialsValerie K Arnold, Frank A López, Ann C Childress, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 25, 2008
Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorderTimothy E Wilens, Samuel W Boellner, Frank A López, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 28, 2018
Fundamentals of leading, tools for managing, and strategies for sustaining changeTravis B Dick, Nathan R Ash, B C Childress, et al.
Journal of Child and Adolescent Psychopharmacology|August 30, 2019
A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across SettingsAnn C Childress, Andrew J Cutler, Andrea Marraffino, et al.
Journal of Global Antimicrobial Resistance|September 14, 2017
Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA)Jayasimha Rao, Dwi Susanti, Johnathon C Childress, et al.
Abdominal Imaging|September 7, 2014
Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancerD I Glazer, M S Davenport, S Khalatbari, et al.
Pageof 9